To revolutionize lifespan extension, we need breakthrough biomarkers of aging
Summary: The discovery of biomarkers for aging could reduce the time and costs required to develop drugs that extend lifespan. Brady Hartman is the author. The original version of this article appeared on LongevityFacts.com.
Biomarkers for aging could revolutionize the development and delivery of drugs that extend lifespan. They would help to get them from the lab into the clinic at a fraction the time and cost. Scientists who are able to develop a biomarker that is effective in aging will be able to make a real breakthrough in the field of life-extension.
Imagine geroscientists just created a compound called Regulus, which promises to increase human lifespans in a significant way. Regulus would be difficult to test because humans are known for living a long life. Regulus could be tested on mice. However, researchers will still need to test its effects on humans. Regulus would have to undergo a costly and long clinical trial before anti-aging doctors could prescribe it.
Source:
We Need Breakthrough Biomarkers of Aging to Revolutionize Lifespan Extension
